Royal Bank of Canada Lowers Avalo Therapeutics (NASDAQ:AVTX) to Sector Perform
Royal Bank of Canada cut shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) from an outperform rating to a sector perform rating in a research note issued to investors on Tuesday morning, The Fly reports. Avalo Therapeutics Trading Down 13.2 % Shares of NASDAQ AVTX opened at $0.37 on Tuesday. The company has a market […]